Drug discovery market was valued at $71.8 billion in 2025 and is projected to reach $178.06 billion by 2035, growing at a CAGR of 9.6% during the forecast Period (2026-2035). The growth of the drug discovery market is driven by the increasing need for therapeutic solutions across healthcare sectors, where the prevalence of chronic and infectious diseases requires ongoing research activity. The demand for faster identification of drug candidates, improved efficacy, and reduced development timelines has led to wider use of advanced discovery tools and platforms. Market activity is influenced by technological developments in high-throughput screening, computational drug design, and artificial intelligence, as well as the emphasis on reducing clinical attrition through data-driven early-stage research.

DNA vaccine market was valued at $960 million in 2025 and is projected to reach $1,475 million by 2035, growing at a CAGR of 4.5% during the forecast Period (2026-2035). The global DNA vaccine market is driven by increasing demand from pharmaceutical companies, biotechnology firms, and public health institutions, where rapid development capability, genetic stability, scalability, and targeted immune response are important technical requirements. DNA vaccines are applied in infectious disease prevention, oncology research, and veterinary medicine to support immunization programs and disease control initiatives.

The congenital heart disease market was valued at $4.8 billion in 2025 and is projected to reach $10.5 billion by 2035, growing at a CAGR of 8.2% during the forecast Period (2026-2035). The growth of the global congenital heart disease (CHD) market is driven by increasing demand from hospitals, specialty cardiac centers, and pediatric healthcare providers for advanced diagnostic, surgical, and interventional treatment solutions. Congenital heart disease encompasses a range of structural abnormalities of the heart present at birth, requiring early diagnosis, long-term clinical management, and, in many cases, surgical or catheter-based interventions. Market demand is primarily concentrated in pediatric cardiology and neonatal care settings, where timely detection and specialized treatment are critical to improving survival rates and long-term patient outcomes.

China air conditioning market size reached $38.0 billion in 2025 and is projected to expand to $56.6 billion by 2035, growing at a CAGR of 4.2% during the forecast period (2026–2035). Market growth is supported by urban infrastructure expansion, rising residential cooling demand, and regulatory efficiency standards.

The brain-computer interface market was valued at $280.2 million in 2025 and is projected to reach $865.0 million by 2035, growing at a CAGR of 12.0% during the forecast period (2026-2035). The growth of the global Brain–Computer Interface (BCI) market is driven by increasing demand from healthcare providers, research institutions, and technology developers for systems that enable direct communication between the human brain and external devices. BCI technologies are designed to acquire and interpret neural signals and convert them into commands for applications including assistive communication, neuroprosthetics, rehabilitation systems, and human–machine interaction. Market demand is primarily concentrated in the healthcare and medical research sectors, where BCI solutions are used to support patients with neurological disorders, spinal cord injuries, and motor impairments.

Biobanking market was valued at $8.3 billion in 2024 and is projected to reach $20.1 billion by 2035, growing at a CAGR of 8.4% during the forecast period (2025–2035). The global biobanking market growth is driven by increasing demand for biological sample storage and management to support clinical research, precision medicine, and drug discovery activities worldwide. The adoption of biobanking solutions is influenced by technological advancements in automated sample handling systems, digital management platforms, and laboratory information management systems (LIMS), as well as the expanding role of biobanks in genomics, personalized medicine, and multi-omics research. Regulatory frameworks and ethical standards in major markets support standardized biobank operations, including protocols for sample collection, storage, and data governance, which contribute to wider market adoption.

Bioabsorbable stents market was valued at $150.3 million in 2025 and is projected to reach $242.9 million by 2035, growing at a CAGR of 5.0% during the forecast period (2026-2035). The rising adoption of bioabsorbable stents in cardiovascular and vascular treatments is transforming interventional procedures by offering temporary vessel support without leaving permanent implants. These stents gradually dissolve within the body after restoring blood flow, reducing long-term complications associated with traditional metallic stents. Bioabsorbable stents are widely used in coronary artery disease, peripheral artery disease, and pediatric cardiology, supporting safer and more natural vessel healing.

Asia-Pacific Breathalyzer market size reached $860.6 million in 2024 and is projected to expand to $5,194.8 million by 2035, growing at a CAGR of 17.8% during the forecast period (2025–2035). Market growth is supported by rising road safety regulations, stricter drunk-driving enforcement, and increased workplace alcohol testing requirements.

Asia-Pacific air conditioning market size reached $64.9 billion in 2025 and is projected to expand to $96.2 billion by 2035, growing at a CAGR of 4.1% during the forecast period (2026–2035). Market growth is supported by urbanization, construction activity, and rising cooling demand across residential and commercial buildings.

Animal vaccine market was valued at $13.5 billion in 2024 and is projected to reach $38.7 billion by 2035, growing at a CAGR of 10.1% during the forecast period (2025-2035). The growth of the global animal vaccine market is driven by increasing demand for livestock and poultry products across developed and emerging economies. Higher consumption of meat, dairy, eggs, and aquaculture products has led producers to place greater emphasis on animal health management to maintain production levels and reduce disease-related losses. Vaccination is used as a preventive measure to control disease outbreaks, improve herd health, and support the continuity of food supply chains. As commercial farming systems expand, routine immunization practices are being adopted across cattle, poultry, swine, and aquaculture segments.